Article
The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression.
Haematologica - 1 Dec 2014
Kuo Yuan-Yeh, Hou Hsin-An, Chen Yin-Kai, Li Li-Yu, Chen Po-Hsuen, Tseng Mei-Hsuan, Huang Chi-Fei, Lee Fen-Yu, Liu Ming-Chih, Liu Chia-Wen, Chou Wen-Chien, Liu Chieh-Yu, Tang Jih-Luh, Yao Ming, Tien Hwei-Fang
Abstract excerpt
CXC chemokine receptor 4 (CXCR4) is an essential regulator for homing and maintenance of hematopoietic stem cells within the bone marrow niches. Analysis of clinical implications of bone marrow CXCR4 expression in patients with acute myeloid leukemia showed not only higher CXCR4 expression was an independent poor prognostic factor, irrespective of age, white blood cell counts, cytogenetics, and mutation status of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
